On the heels of a $42 million supply contract with the U.S. Department of Defense, France’s Valneva has netted another big funding source. Through a loan with…

Just as efforts to develop a vaccine against Zika intensified this month, Congress left on vacation without passing a Zika funding bill, potentially delaying…

With HPV rates on the rise in the U.K., researchers are pushing health authorities to include boys in an HPV vaccination program currently offered to females…

Already the world’s best-selling vaccine, Pfizer’s Prevnar 13 got yet another boost Tuesday with an expanded FDA approval in adults aged 18 to 49.

After months of work under the radar, GlaxoSmithKline committed to entering the Zika R&D field, announcing on Thursday that it’s pairing with the National…

Lending its vaccines expertise to a leading Zika candidate, Sanofi has teamed up with the U.S. Army’s Walter Reed Army Institute of Research to guide an…

Researchers already knew that the protection offered by GlaxoSmithKline’s malaria vaccine--the world’s first--wanes over time. But new data shows it may…

In a study that could provide a needed boost for malaria vaccine research, a team in Australia has blocked P. falciparum parasites from infecting human red…

The Zika virus is spreading in the U.S. with nearly 3,000 infections reported. U.S. funding that could lead to a vaccine to slow the virus is tied up in…